In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total ...

Five years ago this month, Britain entered its first Covid lockdown. Streets were emptied, families separated and the NHS ...

For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...

The moment President Donald Trump said he wanted to "thank" the CEO of Pfizer, Albert ... childhood vaccines as of January 2025. There has also been growing suspicion of the COVID-19 vaccine ...

Pfizer CEO Albert Bourla, under pressure from activist ... using the technology behind the revolutionary mRNA vaccines that tackled the coronavirus that caused COVID-19. October 16, 2024 US ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla ... to respond to COVID-19, including our ...

Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in ... said Pfizer chief executive Albert Bourla. The study involved adults who had ...

For most of the past year and 2025, its share price performance has depended on its cancer drugs and HPV vaccine ... CEO Dr. Albert Bourla and praised the firm’s role in the coronavirus pandemic.

German COVID-19 vaccine maker ... a COVID-19 vaccine patent held by Moderna . Pfizer could use existing US manufacturing to counter potential tariff hit Pfizer CEO Albert Bourla said on Monday ...